Skip to content
Screener

10x Genomics, Inc. TXG Intangibles (Net)

Intangibles (Net) at other companies

TEC
Bio-TechneTECH
$319.07M-28.1%
Bruker logo
BrukerBRKR
$867.8M-10.5%
Illumina logo
IlluminaILMN
$410M+72.3%
Agilent Technologies logo
Agilent TechnologiesA
$407M-17.8%
Quanterix Corporation logo
Quanterix CorporationQTRX
$109.16M+561%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$166.8M+73.8%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemJune 30, 2026 / Remaining Useful Life in YearsJune 30, 2026 / Gross Carrying AmountJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Intangibles,NetDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated AmortizationDecember 31, 2025 / Intangibles,Net
Developed technology5.8$56,338$(7,458)$48,880$52,639$(3,359)$49,280
Technology licenses8.322,504(10,226)12,27822,504(9,491)13,013
Assembled workforce01,328(1,326)21,328(1,292)36
Customer Relationships0945(945)945(945)
Total intangible assets, net$81,115$(19,955)$61,160$77,416$(15,087)$62,329

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s intangibles (net)?
10x Genomics, Inc. (TXG) reported intangibles (net) of $61.16M in Q2 2026.
How has 10x Genomics, Inc.'s intangibles (net) changed year-over-year?
10x Genomics, Inc.'s intangibles (net) increased by 315.7% year-over-year, from $14.71M to $61.16M.
What is the long-term trend for 10x Genomics, Inc.'s intangibles (net)?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s intangibles (net) has grown at a 22.8% compound annual growth rate (CAGR), from $22.35M to $62.33M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about 10x Genomics, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude